Gilead Sciences Inc.

NASDAQ: GILD · Real-Time Price · USD
104.16
-2.38 (-2.23%)
At close: May 01, 2025, 12:55 PM

Gilead Sciences Revenue

Gilead Sciences reported an annual revenue of $28.75B, reflecting a 6.04% growth. For the quarter ending December 31, 2024, Gilead Sciences generated $7.57B in revenue.
Revenue (ttm)
$28.75B
Revenue Growth
6.04%
Price / Sales Ratio
4.01
Revenue / Employee
$1.63M
Employees
17,600
Market Cap
129.85B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 28.75B +6.04%
Dec 31, 2023 27.12B -0.60%
Dec 31, 2022 27.28B -0.09%
Dec 31, 2021 27.3B +10.60%
Dec 31, 2020 24.69B n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.